ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Hisamitsu Pharmaceutical Co., Inc. ?
1
Company has very low debt and has enough cash to service the debt requirements
2
Poor long term growth as Net Sales has grown by an annual rate of 2.04% and Operating profit at -3.63% over the last 5 years
3
Flat results in May 25
- CASH AND EQV(HY) Lowest at JPY 247,243 MM
- DEBT-EQUITY RATIO (HY) Highest at -42.71 %
- INVENTORY TURNOVER RATIO(HY) Lowest at 2.64%
4
With ROE of 8.17%, it has a very attractive valuation with a 1.25 Price to Book Value
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -1.68%, its profits have risen by 49.5% ; the PEG ratio of the company is 0.3
- At the current price, the company has a high dividend yield of 0.1
5
Below par performance in long term as well as near term
- Along with generating -1.68% returns in the last 1 year, the stock has also underperformed Japan Nikkei 225 in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Hisamitsu Pharmaceutical Co., Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Hisamitsu Pharmaceutical Co., Inc. for you?
Low Risk, High Return
Absolute
Risk Adjusted
Volatility
Hisamitsu Pharmaceutical Co., Inc.
-1.68%
416.98
25.58%
Japan Nikkei 225
28.54%
1.11
25.75%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
2.04%
EBIT Growth (5y)
-3.63%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.46
Sales to Capital Employed (avg)
0.53
Tax Ratio
21.89%
Dividend Payout Ratio
30.45%
Pledged Shares
0
Institutional Holding
0.06%
ROCE (avg)
10.13%
ROE (avg)
5.31%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
15
Industry P/E
Price to Book Value
1.25
EV to EBIT
11.58
EV to EBITDA
8.67
EV to Capital Employed
1.45
EV to Sales
1.40
PEG Ratio
0.31
Dividend Yield
0.11%
ROCE (Latest)
12.52%
ROE (Latest)
8.17%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
No Trend
Mildly Bullish
OBV
Mildly Bearish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend4What is working for the Company
ROCE(HY)
Highest at 7.3%
RAW MATERIAL COST(Y)
Fallen by -5.78% (YoY
NET PROFIT(9M)
Higher at JPY 15,528.72 MM
-12What is not working for the Company
CASH AND EQV(HY)
Lowest at JPY 247,243 MM
DEBT-EQUITY RATIO
(HY)
Highest at -42.71 %
INVENTORY TURNOVER RATIO(HY)
Lowest at 2.64%
NET SALES(Q)
Lowest at JPY 34,665 MM
OPERATING PROFIT(Q)
Lowest at JPY 5,056 MM
OPERATING PROFIT MARGIN(Q)
Lowest at 14.59 %
PRE-TAX PROFIT(Q)
Lowest at JPY 3,791 MM
NET PROFIT(Q)
Lowest at JPY 2,564 MM
EPS(Q)
Lowest at JPY 35.1
Here's what is working for Hisamitsu Pharmaceutical Co., Inc.
Raw Material Cost
Fallen by -5.78% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Hisamitsu Pharmaceutical Co., Inc.
Pre-Tax Profit
At JPY 3,791 MM has Fallen at -45.18%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (JPY MM)
Net Sales
Lowest at JPY 34,665 MM
in the last five periodsMOJO Watch
Near term sales trend is negative
Net Sales (JPY MM)
Operating Profit
Lowest at JPY 5,056 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (JPY MM)
Operating Profit Margin
Lowest at 14.59 %
in the last five periodsMOJO Watch
Company's profit margin has deteriorated
Operating Profit to Sales
Pre-Tax Profit
Lowest at JPY 3,791 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (JPY MM)
Net Profit
Lowest at JPY 2,564 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is negative
Net Profit (JPY MM)
Net Profit
Fallen at -46.46%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is negative
Net Profit (JPY MM)
EPS
Lowest at JPY 35.1
in the last five periodsMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (JPY)
Cash and Eqv
Lowest at JPY 247,243 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
Debt-Equity Ratio
Highest at -42.71 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Inventory Turnover Ratio
Lowest at 2.64%
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
